Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Insider-Favored Growth Stocks To Watch In January 2025

In This Article:

As global markets continue to react positively to recent political developments and the potential for a trade deal between the U.S. and China, major indices like the S&P 500 have reached record highs, buoyed by enthusiasm for AI investments. In this context of optimism and growth, stocks with high insider ownership can be particularly appealing as they often indicate confidence from those closest to the company's operations.

Top 10 Growth Companies With High Insider Ownership

Name

Insider Ownership

Earnings Growth

Kirloskar Pneumatic (BSE:505283)

30.3%

26.3%

Archean Chemical Industries (NSEI:ACI)

22.9%

41.2%

Laopu Gold (SEHK:6181)

36.4%

36.6%

Waystream Holding (OM:WAYS)

11.3%

113.3%

Medley (TSE:4480)

34.1%

27.3%

Brightstar Resources (ASX:BTR)

16.2%

84.1%

Fine M-TecLTD (KOSDAQ:A441270)

17.2%

135%

Fulin Precision (SZSE:300432)

13.6%

71%

HANA Micron (KOSDAQ:A067310)

18.2%

119.4%

Elliptic Laboratories (OB:ELABS)

26.8%

121.1%

Click here to see the full list of 1470 stocks from our Fast Growing Companies With High Insider Ownership screener.

Here's a peek at a few of the choices from the screener.

MicroTech Medical (Hangzhou)

Simply Wall St Growth Rating: ★★★★★☆

Overview: MicroTech Medical (Hangzhou) Co., Ltd. focuses on the research, development, manufacture, and sale of medical devices for diabetes management both in China and internationally, with a market cap of HK$2.38 billion.

Operations: The company's revenue segment comprises CN¥293.23 million from its operations in developing, manufacturing, and selling medical devices for diabetes care.

Insider Ownership: 25.9%

MicroTech Medical (Hangzhou) is poised for significant growth, with revenue projected to increase by 35.6% annually, outpacing the Hong Kong market's 7.6%. The company is expected to achieve profitability within three years, with earnings forecasted to grow at a substantial rate of 99.57% per year. Despite limited recent insider trading data, high insider ownership aligns management interests with shareholders, potentially enhancing long-term value creation as the company expands its market presence.

SEHK:2235 Ownership Breakdown as at Jan 2025
SEHK:2235 Ownership Breakdown as at Jan 2025

Sino Medical Sciences Technology

Simply Wall St Growth Rating: ★★★★★☆

Overview: Sino Medical Sciences Technology Inc. is a medical device company focused on the research, development, production, and distribution of interventional devices in China with a market cap of CN¥4.06 billion.